{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:47:27Z","timestamp":1776260847469,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.hoc.2018.05.013","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T01:08:45Z","timestamp":1532653725000},"page":"865-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["High-Dose Therapy and Hematopoietic Stem Cell Transplantation in Waldenstr\u00f6m Macroglobulinemia"],"prefix":"10.1016","volume":"32","author":[{"given":"Charalampia","family":"Kyriakou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.hoc.2018.05.013_bib1","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2018.05.013_bib2","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"3","key":"10.1016\/j.hoc.2018.05.013_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","article-title":"The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing","volume":"468","author":"Swerdlow","year":"2016","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.hoc.2018.05.013_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.leukres.2007.02.002","article-title":"The incidence and survival of Waldenstr\u00f6m's Macroglobulinaemia in South East England","volume":"32","author":"Phekoo","year":"2008","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.hoc.2018.05.013_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2141.2001.03144.x","article-title":"Waldenstr\u00f6m macroglobulinaemia: presenting features and outcome in a series with 217 cases","volume":"115","author":"Garcia-Sanz","year":"2001","journal-title":"Br J Haematol"},{"issue":"21","key":"10.1016\/j.hoc.2018.05.013_bib6","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1200\/JCO.2005.06.147","article-title":"Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstr\u00f6m's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system","volume":"23","author":"Baldini","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.hoc.2018.05.013_bib7","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2008-08-174961","article-title":"International prognostic scoring system for Waldenstr\u00f6m macroglobulinemia","volume":"113","author":"Morel","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2018.05.013_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3816\/CLML.2011.n.026","article-title":"Can ISSWM be used for making treatment decisions?","volume":"11","author":"Morel","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1016\/j.hoc.2018.05.013_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/ehm.11.82","article-title":"Risk stratification in Waldenstr\u00f6m macroglobulinemia","volume":"5","author":"Morel","year":"2012","journal-title":"Expert Rev Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2018.05.013_bib10","first-page":"852","article-title":"patients with the description of a new scoring system and its validation on 253 other patients","volume":"96","author":"Morel","year":"2000","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2018.05.013_bib11","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2014-03-565135","article-title":"Treatment recommendations for patients with Waldenstr\u00f6m macroglobulinemia (WM) and related disorders: IWWM-7 consensus","volume":"124","author":"Dimopoulos","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2018.05.013_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/scd.2005.14.3","article-title":"Peripheral blood stem cell mobilization and harvesting after fludarabine therapy for low-grade lymphoma and chronic lymphocytic leukemia","volume":"14","author":"Nichols","year":"2005","journal-title":"Stem Cells Dev"},{"issue":"1 Suppl","key":"10.1016\/j.hoc.2018.05.013_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbmt.2008.10.022","article-title":"Stem cell transplantation in chronic lymphocytic leukemia","volume":"15","author":"Gribben","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.hoc.2018.05.013_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/bmt.2008.360","article-title":"High-dose therapy with autologous PBSC transplantation in the front-line treatment of Waldenstr\u00f6m's macroglobulinemia","volume":"43","author":"Caravita","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.hoc.2018.05.013_bib15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1365-2141.1999.01461.x","article-title":"High-dose therapy with autologous haemopoietic stem cell support for Waldenstr\u00f6m's macroglobulinaemia","volume":"105","author":"Desikan","year":"1999","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2018.05.013_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/sonc.2003.50080","article-title":"Role for high-dose therapy with autologous hematopoietic stem cell support in Waldenstr\u00f6m's macroglobulinemia","volume":"30","author":"Munshi","year":"2003","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2018.05.013_bib17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbmt.2007.01.083","article-title":"Autologous stem cell transplantation as part of first-line treatment of Waldenstr\u00f6m's macroglobulinemia","volume":"13","author":"Dreger","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.hoc.2018.05.013_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1179\/102453308X315915","article-title":"The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study","volume":"13","author":"Gilleece","year":"2008","journal-title":"Hematology"},{"issue":"12","key":"10.1016\/j.hoc.2018.05.013_bib19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.bmt.1703580","article-title":"Stem cell transplantation (SCT) for Waldenstr\u00f6m's macroglobulinemia (WM)","volume":"29","author":"Anagnostopoulos","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.hoc.2018.05.013_bib20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2006.04.010","article-title":"Autologous or allogeneic stem cell transplantation in patients with Waldenstr\u00f6m's macroglobulinemia","volume":"12","author":"Anagnostopoulos","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.hoc.2018.05.013_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/sonc.2003.50048","article-title":"Transplantation in Waldenstr\u00f6m's macroglobulinemia\u2013the French experience","volume":"30","author":"Tournilhac","year":"2003","journal-title":"Semin Oncol"},{"issue":"13","key":"10.1016\/j.hoc.2018.05.013_bib22","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1200\/JCO.2009.24.4905","article-title":"High-dose therapy and autologous stem-cell transplantation in Waldenstr\u00f6m macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation","volume":"28","author":"Kyriakou","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2018.05.013_bib23","unstructured":"Kyriakou C. Autologous Stem Cell Transplantation (ASCT) for the Treatment of Patients with Waldenstr\u00f6m\u2019s Macroglobulinemia\/Lymphoplasmacytic Lymphoma (WM\/LPL). a Risk Factor Analysis By the European Society for Blood and Marrow Transplantation (EBMT) Lymphoma Working Party. 56 th Annual American Society of Hematology Meeting. San Francisco, December 1\u20134, 2014."},{"issue":"4","key":"10.1016\/j.hoc.2018.05.013_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.bmt.1705748","article-title":"Evidence of graft-versus-Waldenstr\u00f6m's macroglobulinaemia effect after allogeneic stem cell transplantation: a single centre experience","volume":"40","author":"Stakiw","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.hoc.2018.05.013_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bmt.1703190","article-title":"Successful non-myeloablative allogeneic peripheral blood stem cell transplantation (PBSCT) for Waldenstr\u00f6m's macroglobulinemia with severe pancytopenia","volume":"28","author":"Ueda","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.hoc.2018.05.013_bib26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bmt.1703041","article-title":"High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstr\u00f6m's macroglobulinemia","volume":"27","author":"Anagnostopoulos","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.hoc.2018.05.013_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.bmt.1705702","article-title":"Long-term graft-versus-Waldenstr\u00f6m macroglobulinemia effect following reduced intensity conditioning allogeneic stem cell transplantation","volume":"40","author":"Meniane","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.hoc.2018.05.013_bib28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/sonc.2003.50052","article-title":"Autologous and allogeneic stem cell transplantation in Waldenstr\u00f6m's macroglobulinemia: review of the literature and future directions","volume":"30","author":"Anagnostopoulos","year":"2003","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2018.05.013_bib29","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3324\/haematol.2009.017814","article-title":"Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenstr\u00f6m's macroglobulinemia. Results of a retrospective analysis of the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire","volume":"95","author":"Garnier","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2018.05.013_bib30","unstructured":"Maloney DG, Anderson LD. Evidence for GVWM following mini-allo in WM. Fred Hutchinson Cancer Research Center (FHCRC) and the University of Washington, Seattle, WA, USA. Abstract 147; Session VIII: Transplant Therapy of Waldenstr\u00f6m\u2019s Macroglobulinemia; International Waldenstrom Macroglobulinemia Workshop; Stockholm, Sweden, 2008."},{"issue":"33","key":"10.1016\/j.hoc.2018.05.013_bib31","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1200\/JCO.2009.27.3607","article-title":"Allogeneic stem-cell transplantation in patients with Waldenstr\u00f6m macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation","volume":"28","author":"Kyriakou","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2018.05.013_bib32","doi-asserted-by":"crossref","unstructured":"Kyriakou C. Long-Term Outcome of Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Waldenstr\u00f6m Macroglobulinemia (WM)-a Retrospective Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT) 58th Annual American Society of Hematology Meeting. San Diego, December, 2016.","DOI":"10.1182\/blood.V128.22.4661.4661"},{"issue":"1","key":"10.1016\/j.hoc.2018.05.013_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbmt.2016.10.010","article-title":"Allogeneic transplantation for relapsed Waldenstr\u00f6m macroglobulinemia and lymphoplasmacytic lymphoma","volume":"23","author":"Cornell","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858818307391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:10:56Z","timestamp":1760184656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858818307391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0889858818307391"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2018.05.013","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-Dose Therapy and Hematopoietic Stem Cell Transplantation in Waldenstr\u00f6m Macroglobulinemia","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2018.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}